top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances and Novel Treatment Options in Metastatic Melanoma
Advances and Novel Treatment Options in Metastatic Melanoma
Autore Facchiano Antonio
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (528 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato ABT-737
acetazolamide
acetylcholine
adjuvant therapy
amoeboid motility
angiogenesis
apoptosis
arthralgia
Bcl-2 family
BCL2L10
biomarkers
BRAF
BRAF inhibitor
BRAF inhibitors
BRAF-mutant melanoma
cancer
cancer associated fibroblast
cancer stem cells
carbonic anhydrase
cell therapy
checkpoint inhibitor
cholinergic system
combined therapy
ctDNA
CXCL10
cyclopamine
cytokines
cytotoxicity
diagnosis
DOCK4
drug resistance
essential oils
exosomes
extracellular vesicles
FAK
hedgehog
HIPPO
HuR
immunity
immunotherapy
interferon
invasion
ipilimumab
lactate dehydrogenase
lipid metabolism
liquid biopsy
liver-directed-therapies
machine learning
MANS peptide
MARCKS
mechanism of action
melanoma
melanoma immune infiltrate
melanoma markers
melanoma metastasis
melanoma PDX
melanomagenesis
metalloproteinases
metastases
metastasis
metastatic dormancy
metastatic therapy
metastatic uveal melanoma (mUM)
microenvironment
microRNAs
MITF
ML258
motility
mucosal melanoma
muscarinic receptors
n/a
nanoparticles
nicotinic receptors
nivolumab
OXPHOS
patient stratification
PD-1
pembrolizumab
phosphorylation
plasmacytoid dendritic cells
prediction
principal component analysis
prognosis
prognostication
protein tyrosine phosphatase
PTPs inhibitors
Rac1
radiotherapy
resistance
rheumatoid arthritis
sex-hormones
sex/gender
ShcD adaptor protein
siRNA
slow cycling phenotype
small molecules
SOCE
STAT3
Support Vector Machine
survival
target therapy
targeted therapy
targeted-therapy
therapeutic resistance
therapy
TLR
TPC2
tumor microenvironment
tumour microenvironment
uveal melanoma (UM)
WNT5A
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557612103321
Facchiano Antonio  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology
Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology
Autore Fioravanti Antonella
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (320 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato acute myocardial infarction
ALS
Alzheimer's disease
antioxidants
antisense oligonucleotide
apoptosis
ASH
autophagy
beta cells
breast cancer
cancer
chemoresistance
clinical trial
cross-talk
diabetes
endometriosis
endometriosis-associated ovarian cancer
epithelial-to-mesenchymal transition
HBV
HCC
HCV
high-grade serous ovarian cancer
Huntington's disease
hypoxia
liver cancer
long noncoding RNA
metabolism
microRNA
MicroRNA
MicroRNA (miRNA)
microRNAs
miR-27a-5p
miR526b
miR655
miRNA
miRNAs
mitochondrial dysfunction
n/a
NAFLD
NASH
neurodegeneration
NF-κB
nitrosative stress. exosome
noncoding RNA
nucleic acid medicine
osteoarthritis
oxidative stress
pancreatic cancer
Parkinson's disease
physiology
reactive oxygen species
reactive oxygen species (ROS)
redox signaling
resistin
ROS
signal transduction
siRNA
superoxide (SO)
synovial fibroblasts
synovitis
systemic lupus erythematosus
therapeutic resistance
therapeutic target
therapeutic tolerance
Thioredoxin Reductase 1 (TXNRD1)
thyroid hormone
translation regulation
visfatin
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557526003321
Fioravanti Antonella  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Aspects of Cancer Stem Cell Biology : Implications for Innovative Therapies
New Aspects of Cancer Stem Cell Biology : Implications for Innovative Therapies
Autore Cavallaro Ugo
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (208 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato ALDH1
ATAC-seq
B4GALT1
bevacizumab
bowel cancer
breast cancer
Cadherin 11
cancer stem cell
cancer stem cells
cancer therapy
cell adhesion molecule
chemo-resistance
chemoresistance
chemotherapy resistance
colon
colorectal
CSCs
dasatinib
early breast cancer
EC-8042
epithelial-mesenchymal transition
exosomes
genetic heterogeneity
genome-wide
HDAC inhibitors
head and neck squamous cell carcinoma
immunohistochemistry
L1CAM
lipid
LUAD
lung cancer
metabolism
neoadjuvant chemotherapy
NSCLC
oral cancer risk
oral epithelial dysplasia
oral squamous cell carcinoma
organoid
ovarian cancer
Ovarian cancer
RNA-seq
saracatinib
SNP array
solid cancer
SOX2
SRC
stem cell
therapeutic resistance
therapy resistance
TNBC
transcriptome
tumor progression
tumoroid
Wnt signaling
WNT signaling
β-catenin
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti New Aspects of Cancer Stem Cell Biology
Record Nr. UNINA-9910557112003321
Cavallaro Ugo  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Prognostic and Predictive Markers in Cancer Progression
New Prognostic and Predictive Markers in Cancer Progression
Autore Costantini Susan
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (294 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato acetyltransferase
AKT
antigen processing machinery (APM) molecules
AR
biomarker
biomarkers
bladder cancer
blood
BRCA1/2
breast cancer
cancer
cancer immunotherapy
cancer prognosis
carcinogenesis
cardioncology
cardiotoxicity
castration-resistant prostate cancer (CRPC)
CD8+ T effector cells
chemo-/radio resistance
CSC
CTCs
cytokines
EMT
eribulin
genetic syndromes
genomic mutations
head and neck cancer
head and neck neoplasms
head and neck tumors
HRR
HUB nodes
human leukocyte antigen (HLA)
hyperglycemia
immune checkpoint inhibitor
K-RAS oncogene
laryngeal cancer
lifestyle habit
major histocompatibility complex (MHC)
MAPK
melanoma
melanoma resistance to MAPK/MEK inhibitors
metabolomics
metastasis
microRNA
miRNA
MSI2
mTOR
musashi 2
mutations
N-cadherin
n/a
NAA10
new metastasis
nivolumab
oncogene dependency
oral cancer
OSCC
pancreatic cancer
paraganglioma
PDL1
pheochromocytoma
PI3K
PI3KCA
prediction
prognosis
prostate cancer
PTEN
resistance to immune checkpoint inhibitors
selenoproteins
targeted therapies
therapeutic resistance
therapeutic target
TILs
TNBC
transcriptomics
tumor predisposition
WNT
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557794803321
Costantini Susan  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The Shaping of Cancer by the Tumour Microenvironment and Its Relevance for Cancer Therapy
The Shaping of Cancer by the Tumour Microenvironment and Its Relevance for Cancer Therapy
Autore Madureira Patrícia Alexandra Saraiva
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (307 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato 3D co-culture
biomarker
biomarkers
bladder cancer
breast cancer
cancer
cancer acidity
cancer cells subpopulations
cancer development
cancer recurrence
cancer stem cells
cancer-associated fibroblast (CAF)
carcinoma
chemotherapy response
clinical trials
colon cancer
cross-presentation
CTLA-4
cytokine/chemokine
darwinian evolution
diclofenac
evolutionary therapy
extracellular matrix (ECM)
feline mammary carcinoma
glioblastoma (GB)
glioma stem cells (GSC)
growth factors
head and neck cancer
histone modification
hyperosmolarity
hypoxia
Hypoxia Inducible Factor (HIF)
immune cell infiltration
immunomodulatory roles
immunotherapy
inhibitor
KDM5B
koningic acid
lung cancer
macrophages
mammary gland
metastasis
microenvironment
molecular docking
molecular subtypes of pancreatic cancer
myeloid cells
myeloid derived suppressor cells
myeloid-derived suppressor cells
oxidative stress
PAI-1
PAI-2
pancreatic stellate cells
PD-1
PD-L1
plasmin
plasminogen
pre-metastatic niche
preclinical modelling
pro- and anti-tumor immune cells
pro-inflammatory cytokines
prognosis
prostate cancer
radioresistance
radiosensitivity
radiotherapy
radiotherapy dose fractionation
reactive oxygen species
regulatory T cells
repurposing
resistance
S100A10
S100A10 (p11)
signaling pathways
spheroid
stroma
syngeneic model
targeted therapy
therapeutic resistance
TNF-α
triple negative
tumor growth
tumor microenvironment
tumor progression
tumor-associated macrophages
tumour microenvironment
uPA
uPAR
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557354203321
Madureira Patrícia Alexandra Saraiva  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui